Skip to main content
2025 STS Annual Meeting Main banner
Back

General Thoracic

Lung Cancer Challenges in Resectable Disease: It's a Whole New World

Debate: Yes—Neoadjuvant Therapy for Node-Negative NSCLC

Sunday, January 26, 2025
12:46pm – 12:52pm PT
Location: 408A

    Invited Speaker(s)

  • Nathaniel R. Evans, III, MD (he/him/his)

    Chief, Division of Thoracic and Esophageal Surgery
    Thomas Jefferson University
    Philadelphia, Pennsylvania, United States

    Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Bristol Myers Squib: Advisory Board (Ongoing); Intuitive Surgical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck: Advisory Board (Ongoing), Speaker (Ongoing)

Disclosure(s):
Nathaniel R. Evans, MD, III: Astra Zeneca: Advisory Board (Ongoing); Bristol Myers Squib: Advisory Board (Ongoing); Intuitive Surgical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck: Advisory Board (Ongoing), Speaker (Ongoing)